Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 14, 2007; 13(6): 858-865
Published online Feb 14, 2007. doi: 10.3748/wjg.v13.i6.858
Published online Feb 14, 2007. doi: 10.3748/wjg.v13.i6.858
Table 1 Clinicopathological characteristics and pancreatic TIC profiles in patients with focal pancreatic mass due to pancreatic carcinoma
| Locationof focalmass | Underlyingchronicpancreatitis | Type of pancreatic TIC of | Histopathology of | |||||||||
| Preoperative | operative | proximal | focal | distal | proximal | focal | distal | |||||
| Case No. | Age | Sex | diagnosis | procedure | pancreas | mass | pancreas | pancreas | mass | pancreas | ||
| 1 | 53 | M | Ph | Carcinoma | No | PD | I | III | I | Normal | IDC | Normal |
| 2 | 64 | M | Ph | Carcinoma | No | PD | I | III | I | Normal | IDC | Normal |
| 3 | 73 | F | Ph | Carcinoma | No | PD | I | III | II | Normal | IDC | TACP |
| 4 | 52 | F | Ph | Carcinoma | No | PD | I | III | II | Normal | IDC | TACP |
| 5 | 69 | M | Ph | Carcinoma | No | PPPD | I | III | II | Normal | IDC | TACP |
| 6 | 70 | F | Ph | Carcinoma | No | PPPD | I | III | II | Normal | IDC | TACP |
| 7 | 53 | M | Ph | Carcinoma | No | PPPD | I | III | II | Normal | IDC | TACP |
| 8 | 78 | F | Ph | Carcinoma | No | PPPD | I | III | II | Normal | IDC | TACP |
| 9 | 57 | M | Ph | Carcinoma | No | PPPD | I | III | II | Normal | IDC | TACP |
| 10 | 59 | F | Pb | Carcinoma | No | DP | I | III | II | Normal | IDC | TACP |
| 11 | 75 | F | Pb | Carcinoma | No | DP | I | III | II | Normal | IDC | TACP |
| 12 | 75 | F | Pb | Carcinoma | No | DP | I | III | II | Normal | IDC | TACP |
| 13 | 54 | F | Ph | Carcinoma | No | PD | I | IV | I | Normal | IDC | Normal |
| 14 | 63 | M | Ph | Carcinoma | No | PPPD | I | IV | I | Normal | IDC | Normal |
| 15 | 57 | F | Ph | Carcinoma | No | PPPD | I | IV | I | Normal | IDC | Normal |
| 16 | 67 | M | Ph | Carcinoma | No | PD | I | IV | II | Normal | IDC | TACP |
| 17 | 67 | M | Ph | Carcinoma | No | PD | I | IV | II | Normal | IDC | TACP |
| 18 | 59 | M | Ph | Carcinoma | No | PD | I | IV | II | Normal | IDC | TACP |
| 19 | 74 | M | Ph | Carcinoma | No | PD | I | IV | II | Normal | IDC | TACP |
| 20 | 69 | M | Ph | Carcinoma | No | PD | I | IV | II | Normal | IDC | TACP |
| 21 | 73 | M | Ph | Carcinoma | No | PD | I | IV | II | Normal | IDC | TACP |
| 22 | 74 | M | Ph | Carcinoma | No | PPPD | I | IV | II | Normal | IDC | TACP |
| 23 | 61 | M | Ph | Carcinoma | No | PPPD | I | IV | II | Normal | IDC | TACP |
| 24 | 64 | F | Ph | Carcinoma | No | PPPD | I | IV | II | Normal | IDC | TACP |
| 25 | 63 | M | Ph | Carcinoma | No | PPPD | I | IV | II | Normal | IDC | TACP |
| 26 | 68 | M | Ph | Carcinoma | No | PPPD | I | IV | II | Normal | IDC | TACP |
| 27 | 65 | M | Pb | Carcinoma | No | DP | I | IV | II | Normal | IDC | TACP |
| 28 | 76 | M | Pb | Carcinoma | No | DP | I | IV | II | Normal | IDC | TACP |
| 29 | 59 | M | Ph | Carcinoma | Yes | PD | II | III | II | CP | IDC | CP |
| 30 | 75 | F | Ph | Carcinoma | Yes | PPPD | II | IV | II | CP | IDC | CP |
| 31 | 57 | F | Ph | TF- pancreatitis | Yes | palliative | II | IV | II | CP | IDC | CP |
| 32 | 67 | M | Ph | TF-pancreatitis | Yes | PD | II | IV | III | CP | IDC | CP |
| 33 | 79 | F | Ph | Carcinoma | Yes | PPPD | III | IV | III | CP | IDC | CP |
Table 2 Clinicopathological characteristics and pancreatic TIC profiles in patients with focal pancreatic mass due to chronic pancreatitis
| Location | Underlying | Type of pancreatic TIC of | Histopathology of | |||||||||
| Case | of focal | Preoperative | chronic | Operative | proximal | focal | distal | proximal | focal | distal | ||
| No. | Age | Sex | mass | diagnosis | pancreatitis | procedure | pancreas | mass | pancreas | pancreas | mass | pancreas |
| 1 | 70 | M | Ph | TF-pancreatitis1 | Yes | PPPD | II | II | II | CP | CP | CP |
| 2 | 55 | M | Pb | TF-pancreatitis | Yes | MP | II | II | II | CP | CP | CP |
| 3 | 62 | M | Ph | TF-pancreatitis | Yes | PPPD | II | II | III | CP | CP | CP |
| 4 | 47 | M | Pb | TF-pancreatitis | Yes | DP | II | II | III | CP | CP | CP |
| 5 | 63 | M | Ph | TF-pancreatitis1 | Yes | PPPD | III | III | II | CP | CP | CP |
| 6 | 45 | F | Pb | TF-pancreatitis | Yes | DP | III | III | III | CP | CP | CP |
| 7 | 60 | M | Pt | TF-pancreatitis | No | DP | I | II | II | Normal | CP | CP |
| 8 | 51 | F | Pt | TF-pancreatitis | No | DP | I | III | III | Normal | CP | CP |
Table 3 Clinicopathological characteristics and pancreatic TIC profiles in patients with focal pancreatic mass due to islet cell tumor
| Locationof focalmass | Underlyingchronicpancreatitis | Type of pancreatic TIC of | Histopathology of | |||||||||
| Case | Preoperative | Operative | proximal | focal | distal | proximal | focal | distal | ||||
| No. | Age | Sex | diagnosis | procedure | pancreas | mass | pancreas | pancreas | mass | pancreas | ||
| 1 | 63 | M | Ph | Insulinoma | No | PPPD | I | I | I | Normal | Insulinoma | Normal |
| 2 | 68 | M | Pb | Insulinoma | No | MP | I | I | I | Normal | Insulinoma | Normal |
| 3 | 82 | M | Pb | Islet cell tumor | No | DP | I | I | I | Normal | Glucagonoma | Normal |
| 4 | 47 | F | Pb | Islet cell tumor | No | DP | I | I | I | Normal | Glucagonoma | Normal |
| 5 | 70 | M | Ph | Islet cell tumor | No | DPPHR | I | I | I | Normal | NFICT | Normal |
| 6 | 46 | F | Pb | Islet cell tumor | No | DP | I | I | I | Normal | NFICT | Normal |
| 7 | 69 | F | Pb | Islet cell tumor | No | DP | I | I | I | Normal | NFICT | Normal |
- Citation: Tajima Y, Kuroki T, Tsutsumi R, Isomoto I, Uetani M, Kanematsu T. Pancreatic carcinoma coexisting with chronic pancreatitis versus tumor-forming pancreatitis: Diagnostic utility of the time-signal intensity curve from dynamic contrast-enhanced MR imaging. World J Gastroenterol 2007; 13(6): 858-865
- URL: https://www.wjgnet.com/1007-9327/full/v13/i6/858.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i6.858
